1859

Biotechnology ResearchCalifornia, United States11-50 Employees

1859 is a biotechnology research company based in San Diego, California, focused on accelerating drug discovery. The organization combines combinatorial chemistry, pico-scale activity-based screening, and artificial intelligence to generate millions of empirical datapoints each week, helping its models improve over time. This integrated approach supports biologists and medicinal chemists in rapidly identifying novel small-molecule therapeutics for emerging disease targets. The company operates at the intersection of experimental screening and computational modeling within the biotechnology sector, aiming to speed the path from discovery to treatment. In early 2022, 1859 launched as a platform that unites AI with large-scale empirical screening data to pursue new medicines for emerging targets.

Sign up for free to view info

Email Format Employee directory